SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-16-007413
Filing Date
2016-11-14
Accepted
2016-11-14 18:21:25
Documents
52
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtgn10q_sep302016.htm 10-Q 1396768
2 ex10-1.htm EX-10.1 34122
3 ex10-2.htm EX-10.2 63587
4 ex31-1.htm EX-31.1 14126
5 ex31-2.htm EX-31.2 14289
6 ex32.htm EX-32 6978
  Complete submission text file 0001415889-16-007413.txt   3673422

Data Files

Seq Description Document Type Size
7 vsta-20160930.xml EX-101.INS 508940
8 vsta-20160930.xsd EX-101.SCH 41368
9 vsta-20160930_cal.xml EX-101.CAL 41822
10 vsta-20160930_def.xml EX-101.DEF 109560
11 vsta-20160930_lab.xml EX-101.LAB 191959
12 vsta-20160930_pre.xml EX-101.PRE 169795
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 161997095
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences